220 related articles for article (PubMed ID: 33309796)
1. New drug targets for hypertension: A literature review.
Gao Q; Xu L; Cai J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166037. PubMed ID: 33309796
[TBL] [Abstract][Full Text] [Related]
2. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
3. New approaches in the treatment of hypertension.
Oparil S; Schmieder RE
Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
[TBL] [Abstract][Full Text] [Related]
4. Emerging drugs which target the renin-angiotensin-aldosterone system.
Steckelings UM; Paulis L; Unger T; Bader M
Expert Opin Emerg Drugs; 2011 Dec; 16(4):619-30. PubMed ID: 21905943
[TBL] [Abstract][Full Text] [Related]
5. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist DJ; Kroon AA; de Leeuw PW
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
[TBL] [Abstract][Full Text] [Related]
7. New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.
Monge M; Lorthioir A; Bobrie G; Azizi M
J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):285-9. PubMed ID: 24222656
[TBL] [Abstract][Full Text] [Related]
8. Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper.
Habib GB; Basra SS
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):516-25. PubMed ID: 24790054
[TBL] [Abstract][Full Text] [Related]
9. The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges.
Mendoza A; Lazartigues E
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):201-8. PubMed ID: 25801471
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
11. Salt, the renin-angiotensin-aldosterone system and resistant hypertension.
Shimosawa T
Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system.
Jankowski P; Safar ME; Benetos A
Curr Pharm Des; 2009; 15(5):571-84. PubMed ID: 19199982
[TBL] [Abstract][Full Text] [Related]
14. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
15. An Overview of the Potential Use of Ethno-Medicinal Plants Targeting the Renin-Angiotensin System in the Treatment of Hypertension.
De Lange-Jacobs P; Shaikh-Kader A; Thomas B; Nyakudya TT
Molecules; 2020 Apr; 25(9):. PubMed ID: 32366012
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
Soldner A; Spahn-Langguth H; Mutschler E
Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
[TBL] [Abstract][Full Text] [Related]
17. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.
Hallow KM; Lo A; Beh J; Rodrigo M; Ermakov S; Friedman S; de Leon H; Sarkar A; Xiong Y; Sarangapani R; Schmidt H; Webb R; Kondic AG
Am J Physiol Regul Integr Comp Physiol; 2014 May; 306(9):R647-62. PubMed ID: 24500431
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension.
Contreras F; de la Parte MA; Cabrera J; Ospino N; Israili ZH; Velasco M
Am J Ther; 2003; 10(6):401-8. PubMed ID: 14624277
[TBL] [Abstract][Full Text] [Related]
20. The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
Siragy H; Huang J; Lieb DC
Expert Opin Emerg Drugs; 2008 Sep; 13(3):417-30. PubMed ID: 18764720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
